Headquarters: Los Angeles, California, United States
Total Funding: 63200000.0
Founded Date: 2016-01-01
Last Funding Type: Series B
Investors Number: 18.0
Last Funding Date: 2022-11-28
Technology: Rare Genetic Disorders
Funding Status: Early Stage Venture
Industry: Early Drug Development